Loading company…
Nottingham-based contract research, development and manufacturing organization for pharmaceutical and biotech drug development.
Established in 1990 and headquartered in Nottingham, UK, Quotient Sciences offers integrated CRDMO services, including formulation development, clinical trial manufacturing and commercial drug product manufacturing, for pharmaceutical and biotechnology companies. Permira acquired a majority stake from GHO Capital in July 2019. The company raised a total of GBP 165.00 mn through a Secondary Buyout on July 18, 2019, has completed three deals, and reported revenue of GBP 92,387,062.40 and EBITDA of GBP 18,549,560.70 for the fiscal year ending 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in